Skip to main content
Download PDF
Download ePub

Correction: CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus

Cardiovascular Diabetology volume 22, Article number: 196 (2023) Cite this article

The Original Article was published on 07 July 2023

Correction: Cardiovascular Diabetology (2023) 22:172 https://doi.org/10.1186/s12933-023-01900-w


Following publication of the original article [1], the author noticed an error in the images of Fig. 6H. The two images of Fig. 6H filled with red colours without any pictures which has been incorrectly processed by the typesetting team. This has now been corrected with this erratum (Fig. 6).

Fig. 6
figure 6figure 6

The neovascularization and wound healing were improved in STZ-induced CXCL5KO diabetic mice. CXCL5 knockout mice had rarely circulating CXCL5 (n = 6; A). Representative evaluation of the ischemic (right) and nonischemic (left) hindlimbs before, immediately after 2 weeks and 4 weeks after the hindlimb ischemia surgery in STZ induced type 1 diabetic mice (n = 6; B). The number of circulating EPCs was determined by flow cytometry in STZ induced type 1 diabetic mice. Deletion of CXCL5 expression increased the number of circulating EPCs after ischemia surgery compared with DM (n = 6; C). Anti-CD31 immunostaining showed that inhibition of CXCL5 expression significantly increased the number of capillaries. Scale bar, 50 µm (n = 6; D). Western blotting and statistical analyses of VEGF and SDF-1 in the ischemia leg (n = 3; E). Representative matrigel plug and analysis of hemoglobin content (n = 6; F). Representative matrigel plug images with immunostaining of CD31. CD31 positive areas were enhanced in the CXCL5 knockout diabetic mice. Scale bar, 50 µm (G). CXCL5 inhibition by knockout improved wound repair ability in STZ induced type 1 diabetic mice. Representative wound areas and the closure rates of 3-mm punch biopsies were measured (n = 6; H). Representative wound area images with immunostaining of CD31. CD31 positive areas were enhanced in the CXCL5 knockout mice. Scale bar, 50 µm (I). CXCL5, Chemokine C-X-C motif ligand 5; CXCL5KO, CXCL5-knockout mice; CXCL5KO + STZ, CXCL5 knockout diabetic mice. DM diabetes mellitus, EPC endothelial progenitor cell, STZ streptozotocin, WT wild-type mice, WT + STZ wild-type diabetic mice. The Mann–Whitney U test was used to determine statistically significant differences. *p < 0.05, **p < 0.01 compared with the WT group. #p < 0.05, ##p < 0.01 compared with the WT + STZ group

Full size image

The original article has been corrected.

Reference

  1. Chen C, Lin LY, Chen JW, Chang T-T. CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus. Cardiovasc Diabetol. 2023;22:172. https://doi.org/10.1186/s12933-023-01900-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Ching Chen, Jaw-Wen Chen & Ting-Ting Chang

  2. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Ching Chen, Liang-Yu Lin, Jaw-Wen Chen & Ting-Ting Chang

  3. Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

    Liang-Yu Lin

  4. Healthcare and Services Center, Taipei Veterans General Hospital, Taipei, Taiwan

    Jaw-Wen Chen

  5. Division of Cardiology, Department of Medicine, Taipei Medical University Hospital, Taipei, Taiwan

    Jaw-Wen Chen

  6. Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Jaw-Wen Chen

  7. Taipei Cardiovascular Research Center, Taipei Medical University, Taipei, Taiwan

    Jaw-Wen Chen

  8. Biomedical Industry, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Ting-Ting Chang

Authors
  1. Ching Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liang-Yu Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jaw-Wen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ting-Ting Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ting-Ting Chang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, C., Lin, LY., Chen, JW. et al. Correction: CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus. Cardiovasc Diabetol 22, 196 (2023). https://doi.org/10.1186/s12933-023-01929-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12933-023-01929-x

Cardiovascular Diabetology

ISSN: 1475-2840